Drug Search Results

TP508

Alternative Names: tp508, chrysalin
Latest Update: 2024-11-18
Latest Update Note: News Article

Product Description

Mechanisms of Action: Thrombin

Novel Mechanism: Yes

Modality: Large Molecule

Route of Administration: Percutaneous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Taiwan

Approved Indications: None

Known Adverse Events: None

Company: Capstone
Company Location: TEMPE AZ 85281
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Radius Fractures

Trial	Phase	Trial Status	Disease	Primary Completion Date	Probability of Success
OL-ADRFX-03	P2	Terminated	Radius Fractures	2007-03-01

Recent News Events

Date	Type	Title
11/18/2024	News Article	Chrysalis BioTherapeutics, Inc. Announces Collaboration with NIAID to Evaluate Chrysalin® for the Treatment of Cutaneous Radiation Injury
05/15/2024	PubMed	Effects of ivermectin on development of Calliphora vicina, Robineau-Desvoidy 1830 (Diptera, Calliphoridae).
05/14/2024	PubMed	Investigation of Fungal Community Structure in the Gut of the Stag Beetle Dorcus hopei (Coleoptera; Lucanidae): Comparisons Among Developmental Stages.
05/13/2024	PubMed	Cyp6g2 is the major P450 epoxidase responsible for juvenile hormone biosynthesis in Drosophila melanogaster.
05/06/2024	News Article	Chrysalis BioTherapeutics Selected to Present at Respiratory Innovation Summit
09/26/2023	News Article	Chrysalis Receives FDA Approval to Initiate Clinical Trials with Chrysalin™ (TP508)
12/01/2020	News Article	Chrysalis BioTherapeutics Receives $10.4 Million From BARDA to Continue Development of TP508 as a Nuclear Countermeasure

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions